Log in with your email address username.


Important notice

doctorportal Learning is on the move as we will be launching a new website very shortly. If you would like to sign up to dp Learning now to register for CPD learning or to use our CPD tracker, please email support@doctorportal.com.au so we can assist you. If you are already signed up to doctorportal Learning, your login will work in the new site so you can continue to enrol for learning, complete an online module, or access your CPD tracker report.

To access and/or sign up for other resources such as Jobs Board, Bookshop or InSight+, please go to www.mja.com.au, or click the relevant menu item and you will be redirected.

All other doctorportal services, such as Find A Doctor, are no longer available.

[Comment] Baricitinib for systemic lupus erythematosus

Despite improvements in diagnostics and therapy over the past few decades, diagnosis of systemic lupus erythematosus is still associated with significant mortality and severe burden. Belimumab is the only new drug licensed during the past 50 years for systemic lupus erythematosus; therefore, any success of a drug in the pipeline raises new hope for patients and the scientific community.